The presented study shows some of the possible directions for future research to bring us closer to the full understanding of the dysfunctional high-density lipoprotein and the role of myeloperoxidase (MPO) and paraoxonase-1 (PON-1) in patients with ischemic heart disease and type 2 diabetes. The gene discussed is MPO; the disease is type 2 diabetes mellitus.